Property:Outcome specification
This is a property of type Text.
H
Hodgson et al. (2012): Reflexology versus Swedish Massage to Reduce Physiologic Stress and Pain and Improve Mood in Nursing Home Residents with Cancer: A Pilot Trial. +
All endpoints are mean values formed from four surveys that took place over each intervention day
Observation of state of mind AARS: Positive affect +
Hodgson et al. (2012): Reflexology versus Swedish Massage to Reduce Physiologic Stress and Pain and Improve Mood in Nursing Home Residents with Cancer: A Pilot Trial. +
NA +
Hodgson et al. (2012): Reflexology versus Swedish Massage to Reduce Physiologic Stress and Pain and Improve Mood in Nursing Home Residents with Cancer: A Pilot Trial. +
Observation of state of mind AARS: Negative affect +
Hoopfer et al. (2015): Three-arm randomized phase III trial: Quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy +
'''Acute skin reactions'''
Were scored using a modified 10-point Catterall skin scoring profile.
1 no visible reaction
2 light erythema
3 moderate erythema
4 severe erythema
5 dry desquamation < 50% of irradiated area
6 dry desquamation > 50% of irradiated area
7 blistering present
8 moist desquamation < 50% of the irradiated area
9 moist desquamation > 50% of irradiated field
10 ulceration present +
Hoopfer et al. (2015): Three-arm randomized phase III trial: Quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy +
'''Perceived Symptoms'''
The participants scored the severity of dryness, itchiness, burning, and pain using a 6-point Likert tool
Patient symptom inventory: 0=none/not present; 1=mild; 2=discomfort; 3=distressing; 4=horrible; 5=excruciating +
Hoopfer et al. (2015): Three-arm randomized phase III trial: Quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy +
'''Changes'''
The changes in skin dryness, itchiness, burning sensation, and pain relative to the previous follow-up point were also scored using a 6-point Likert tool. The response options possible relative to the changes in symptoms were:
0=none; 1=unchanged; 2=slightly improved; 3=much improved; 4=slightly worse; 5=much worse. +
Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics +
Potential effects of SRT501 on processes relevant to cell survival and apoptosis were measured in plasma and tissue. +
Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics +
Resveratrol pharmacokinetics in blood (1) and concentration in liver tissue (2):
(1) Patients’ plasma was analysed by HPLC-MS/MS for resveratrol.
(2) Resveratrol was quantified in tumor and normal adjacent hepatic tissues. +
I
Inglis et al. (2020): Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT +
Hand grip, lower body strength, physical performance +
Inglis et al. (2020): Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT +
Phase angle and lean mass +
Iovino et al. (2018): High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation +
NI +
J
Jacot et al. (2016): Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study +
NI +
Jacot et al. (2016): Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study +
Increase of normalization of serum 25OHD, defined as a 25OHD blood-level minimum target of 30 ng/ml +
Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial +
NA +
Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial +
Serum creatinine level and blood urea nitrogen test for renal function assessment and aspartate aminotransferase and alanine transaminase for liver function assessment, recorded daily +
Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial +
Graft-versus-host disease is a condition where the donated stem cells (graft) attack the recipient's body (host) +
Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial +
Neutrophil and platelet engraftment time (the time point after transplantation at which a patient can maintain a sustained ANC of 4500 cells/mm3 and a sustained platelet count of at least 20 000/mm3 lasting 3 consecutive days without transfusions during hospital stay) +
Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial +
NA +